Duplicate Therapy Database™
Improves Clinical Outcomes by Helping to Avoid Unnecessary Therapeutic Duplication
HELPS TO PREVENT DRUG DUPLICATION
Duplicate Therapy Database™ equips health care providers with reliable, timely
alerts to potential duplications in drug therapy. Information in the database
is drug-specific, comprehensive and Screens for drugs with similar primary indications
or active ingredients.
FEATURES
- Therapeutic duplications for products used for single and multiple therapeutic
purposes
- Ingredient duplications for single and multiple ingredient products
- OTC medication duplications
- Codes identifying duplication class, be it an ingredient, mechanism
of action or therapeutic indication
- Significance codes to indicate presence of abuse potential
- Duplication Allowance indicator to specify the number of acceptable
duplications before providing an alert
BENEFITS
FOR HEALTH CARE FACILITIES
- Supports Drug Utilization Review (DUR)
- Identifies duplications related to ingredients, actions
or indications
- Screens for drug duplications with abuse potential
- Improves both clinical and financial outcomes by helping you avoid
toxic or unnecessary therapies
- Reduces risks by helping you to identify against unintentional drug duplication associated with the combined use of prescription and OTC medications
- Enhances the safety of patients being treated by multiple
physicians
FOR HEALTH CARE PROVIDERS
- Supports Drug Utilization Review (DUR)
- Identifies duplications related to ingredients, actions
or indications
- Screens for drug duplications with abuse potential
- Improves both clinical and financial outcomes by helping you avoid
toxic or unnecessary therapies
- Reduces risks by helping you to identify unintentional drug duplication associated with the combined use of prescription and OTC medications
- Enhances the safety of patients being treated by multiple
physicians
FOR PAYERS
- Supports Drug Utilization Review (DUR)
- Identifies duplications related to ingredients, actions
or indications
- Screens for drug duplications with abuse potential
- Improves both clinical and financial outcomes by helping you avoid
toxic or unnecessary therapies
- Reduces risks by helping you to identify unintentional drug duplication associated with the combined use of prescription and OTC medications
- Enhances the safety of patients being treated by multiple
physicians
FOR PHARMACISTS
- Supports Drug Utilization Review (DUR)
- Identifies duplications related to ingredients, actions
or indications
- Screens for drug duplications with abuse potential
- Improves both clinical and financial outcomes by helping you avoid
toxic or unnecessary therapies
- Reduces risks by helping you identify unintentional drug duplication associated with the combined use of prescription and OTC medications
- Enhances the safety of patients being treated by multiple
physicians
This database is produced and delivered to customers on a weekly, monthly
or quarterly basis.